Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome

作者：Kano Michiko; Muratsubaki Tomohiko; Van Oudenhove Lukas; Morishita Joe; Yoshizawa Makoto; Kohno Keiji; Yagihashi Mao; Tanaka Yukari; Mugikura Shunji; Dupont Patrick; Huynh Giao Ly; Takase Kei; Kanazawa Motoyori; Fukudo Shin

来源：Scientific Reports, 2017, 7(1): 12425.

DOI：10.1038/s41598-017-09635-x

Stress is a known trigger of irritable bowel syndrome (IBS) and exacerbates its gastrointestinal symptoms. However, underlying the physiological mechanism remains unknown. Here, we investigated hypothalamic-pituitary-adrenal (HPA) axis, colonic motility, and autonomic responses to corticotropin-releasing hormone (CRH) administration as well as brain activity alterations in IBS. The study included 28 IBS patients and 34 age and sex-matched healthy control subjects. IBS patients demonstrated greater adrenocorticotropic hormone (ACTH) responses to CRH than control subjects. Male IBS patients had greater increases in colonic motility than male HCs after CRH. Female IBS patients showed altered sympathovagal balance and lower basal parasympathetic tone relative to female control subjects. Brain responses to rectal distention were measured in the same subjects using functional magnetic resonance imaging, and their associations with individual ACTH responses to CRH were tested. A negative association between ACTH response to CRH and activity in the pregenual anterior cingulate cortex (pACC) during rectal distention was identified in controls but not in IBS patients. Impaired top-down inhibitory input from the pregenual ACC to the HPA axis may lead to altered neuroendocrine and gastrointestinal responses to CRH. Centrally acting treatments may dampen the stress induced physical symptoms in IBS.

• 出版日期2017-9-29